SPOTLIGHT: Hikal wins Pfizer manufacturing deal

An Indian contract manufacturing company is jumping for joy after Pfizer chose it as a supplier of active pharmaceutical ingredients. Hikal will make the APIs at its FDA-approved manufacturing plant in Bangalore. Interestingly, the Indian company had been considering a buyout of Pfizer's Ireland operations, but dropped out of the bidding. Release

Suggested Articles

With a brand new approval for Adakveo under its belt, Novartis Sunday flaunted an analysis showing the drug could cut patient hospitalizations by 40%.

BeiGene only just won its first Brukinsa nod in MCL. But it’s already pushing to join the CLL field, and Sunday it rolled out more data.

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.